Orange Book product · Generic (ANDA)
PROPYLTHIOURACIL
PROPYLTHIOURACIL
At a glance
May 10, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 10, 2023
3 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
PROPYLTHIOURACIL
Strength
50MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 208867
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PROPYLTHIOURACIL
- —PROPYLTHIOURACILBrand (NDA)
NDA 006213 · LILLY
- —PROPYLTHIOURACILBrand (NDA)
NDA 006188 · PH HEALTH
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 084075 · ABBOTT
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 080172 · ACTAVIS ELIZABETH
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 080285 · ANABOLIC
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 080215 · ANI PHARMS
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 080016 · CHARTWELL MOLECULAR
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 084543 · CHARTWELL RX
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 080015 · HALSEY
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 080159 · IMPAX LABS
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 080154 · QUAGEN
- —PROPYLTHIOURACILGeneric (ANDA)
ANDA 083982 · SUN PHARM INDUSTRIES
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
